08 Jul 2022
Research carried out by Mount Sinai, partly funded by the European Community's Seventh Framework Programme, has shown a link between foetal exposure to endocrine disrupting chemicals and the development of non-fatty liver disease. The findings, published in JAMA Network Open, were of particular significance, as this is the first time the potential impact of exposure to these chemicals has been studied in humans.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024